Institutional investors hold a majority ownership of DEPO through the 105.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended March 2015, these large investors purchased a net $9.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OAK RIDGE INVESTMENTS LLC Bought 2.0 Million shares of Depomed Inc
JANUS CAPITAL MANAGEMENT LLC Bought 1.9 Million shares of Depomed Inc
COLUMBUS CIRCLE INVESTORS Bought 1.1 Million shares of Depomed Inc